Variation of Cancer Incidence between and within GRELL Countries.

cancer incidence cancer registry environmental justice geographic analysis regional analysis social inequalities

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
02 09 2021
Historique:
received: 14 07 2021
revised: 26 08 2021
accepted: 27 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 26 10 2021
Statut: epublish

Résumé

Variation in cancer incidence between countries and groups of countries has been well studied. However cancer incidence is linked to risk factors that may vary within countries, and may subsist in localized geographic areas. In this study we investigated between- and within-country variation in the incidence of all cancers combined for countries belonging to the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). We hypothesized that investigation at the micro-level (circumscribed regions and local cancer registry areas) would reveal incidence variations not evident at the macro level and allow identification of cancer incidence hotspots for research, public health, and to fight social inequalities. Data for all cancers diagnosed in 2008-2012 were extracted from Cancer Incidence in Five Continents, Vol XI. Incidence variation within a country or region was quantified as r/R, defined as the difference between the highest and lowest incidence rates for cancer registries within a country/region (r), divided by the incidence rate for the entire country/region × 100. We found that the area with the highest male incidence had an ASRw 4.3 times higher than the area with the lowest incidence. The area with the highest female incidence had an ASRw 3.3 times higher than the area with the lowest incidence. Areas with the highest male ASRws were Azores (Portugal), Florianopolis (Brazil), Metropolitan France, north Spain, Belgium, and north-west and north-east Italy. Areas with the highest female ASRws were Florianopolis (Brazil), Belgium, north-west Italy, north-east Italy, central Italy, Switzerland and Metropolitan France. Our analysis has shown that cancer incidence varies markedly across GRELL countries but also within several countries: the presence of several areas with high cancer incidence suggests the presence of area-specific risk factors that deserve further investigation.

Identifiants

pubmed: 34501852
pii: ijerph18179262
doi: 10.3390/ijerph18179262
pmc: PMC8431723
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
J Clin Neurosci. 2019 Aug;66:121-127
pubmed: 31133367
Lancet. 2014 Feb 8;383(9916):549-57
pubmed: 24351322
Environ Health Perspect. 2015 Feb;123(2):135-43
pubmed: 25343779
Eur J Cancer Prev. 2017 Sep;26(5):442-446
pubmed: 28654436
Lancet Respir Med. 2021 Sep;9(9):1030-1049
pubmed: 34411511
Biomedica. 2012 Oct-Dec;32(4):536-44
pubmed: 23715229
CA Cancer J Clin. 2018 Sep;68(5):324-326
pubmed: 30152865
J Public Health (Oxf). 2017 Sep 1;39(3):464-475
pubmed: 27621336
Cancer Causes Control. 2019 May;30(5):489-499
pubmed: 30895415
J Registry Manag. 2014 Fall;41(3):128-34
pubmed: 25419606
Lancet Oncol. 2013 Aug;14(9):813-22
pubmed: 23849838
Lancet Haematol. 2018 Jan;5(1):e14-e24
pubmed: 29304322
Lancet Oncol. 2015 Jan;16(1):36-46
pubmed: 25467404
Eur Urol. 2015 Jun;67(6):1134-1141
pubmed: 25465966
Int J Environ Res Public Health. 2019 Aug 28;16(17):
pubmed: 31466272
Cancer Epidemiol. 2016 Sep;44 Suppl 1:S23-S42
pubmed: 27678320
Epidemiol Prev. 2015 Sep-Dec;39(5-6):373-9
pubmed: 26554689
J Clin Oncol. 2016 Jan 1;34(1):6-13
pubmed: 26578608
Lancet Oncol. 2013 Apr;14(5):391-436
pubmed: 23628188
Lancet Oncol. 2018 Sep;19(9):1159-1169
pubmed: 30098952

Auteurs

Paolo Contiero (P)

Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Giovanna Tagliabue (G)

Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Gemma Gatta (G)

Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Jaume Galceran (J)

Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Sant Joan de Reus University Hospital, IISPV, 43204 Reus, Spain.

Jean-Luc Bulliard (JL)

Vaud Tumour Registry, Centre for Primary Care and Public Health, University of Lausanne, 1010 Lausanne, Switzerland.
Neuchâtel-Jura Tumour Registry, 2000 Neuchâtel, Switzerland.

Martina Bertoldi (M)

Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Alessandra Scaburri (A)

Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Emanuele Crocetti (E)

Romagna Cancer Registry, Romagna Cancer Institute (IRCCS Istituto Romagnolo Per Lo Studio dei Tumori (IRST) "Dino Amadori"), 47014 Meldola, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH